Stock EHC ENCOMPASS HEALTH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Encompass Health Corporation

Equities

EHC

US29261A1007

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
82.47 USD -0.31% Intraday chart for Encompass Health Corporation +4.10% +23.61%
Apr. 25 Encompass Health Corporation Provides Earnings Guidance for 2024 CI
Apr. 25 Transcript : Encompass Health Corporation, Q1 2024 Earnings Call, Apr 25, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 6,830 8,222 6,493 5,968 6,688 8,259 - -
Enterprise Value (EV) 1 9,798 11,287 9,660 8,682 9,296 10,628 10,550 10,373
P/E ratio 19.2 x 29 x 15.9 x 22.2 x 19.2 x 20.4 x 18.4 x 17.3 x
Yield 1.59% 1.35% 1.72% - 0.9% 0.73% 0.73% 0.73%
Capitalization / Revenue 1.48 x 1.77 x 1.27 x 1.37 x 1.39 x 1.56 x 1.44 x 1.32 x
EV / Revenue 2.13 x 2.43 x 1.89 x 2 x 1.94 x 2.01 x 1.83 x 1.66 x
EV / EBITDA 10.2 x 13.1 x 9.4 x 10.6 x 9.57 x 10.1 x 9.23 x 8.28 x
EV / FCF 19 x 36.6 x 51.7 x 61.6 x 34.7 x 39.7 x 39.6 x 37.2 x
FCF Yield 5.27% 2.74% 1.93% 1.62% 2.88% 2.52% 2.52% 2.68%
Price to Book 5.02 x 5.18 x 3.4 x - - 2.98 x 2.86 x 2.4 x
Nbr of stocks (in thousands) 98,600 99,432 99,492 99,788 100,241 100,140 - -
Reference price 2 69.27 82.69 65.26 59.81 66.72 82.47 82.47 82.47
Announcement Date 2/6/20 1/26/21 2/1/22 2/7/23 2/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,605 4,644 5,122 4,349 4,801 5,297 5,751 6,255
EBITDA 1 964.9 860.3 1,028 819.3 971.1 1,053 1,144 1,253
EBIT 1 692.5 617.3 771.4 575.7 697.2 779.3 851.7 919.9
Operating Margin 15.04% 13.29% 15.06% 13.24% 14.52% 14.71% 14.81% 14.71%
Earnings before Tax (EBT) 1 562.3 472.6 657.2 450.8 607.2 649.7 729.3 793.2
Net income 1 358.7 284.2 412.2 271 352 414.2 458.1 489.4
Net margin 7.79% 6.12% 8.05% 6.23% 7.33% 7.82% 7.97% 7.82%
EPS 2 3.610 2.850 4.110 2.700 3.470 4.040 4.480 4.773
Free Cash Flow 1 516.5 308.7 186.9 141 267.7 267.8 266.4 278.5
FCF margin 11.22% 6.65% 3.65% 3.24% 5.58% 5.06% 4.63% 4.45%
FCF Conversion (EBITDA) 53.53% 35.88% 18.18% 17.21% 27.57% 25.43% 23.3% 22.23%
FCF Conversion (Net income) 143.99% 108.62% 45.34% 52.03% 76.05% 64.64% 58.15% 56.9%
Dividend per Share 2 1.100 1.120 1.120 - 0.6000 0.6000 0.6000 0.6000
Announcement Date 2/6/20 1/26/21 2/1/22 2/7/23 2/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,285 1,319 1,334 1,330 1,090 1,137 1,160 1,187 1,207 1,247 1,316 1,305 1,325 1,360 1,422
EBITDA 1 245.6 252.7 245 240.2 195.3 232.7 229 249.6 237.5 255 273 262.9 257.4 266.1 285.3
EBIT 1 180.7 186.9 178.8 171.4 133.2 169.4 165.1 177 170.2 184.9 202.7 195.6 189.5 196.6 215.3
Operating Margin 14.06% 14.17% 13.41% 12.88% 12.23% 14.89% 14.23% 14.91% 14.1% 14.83% 15.4% 14.99% 14.3% 14.45% 15.14%
Earnings before Tax (EBT) 1 160.9 147.2 141.3 95.1 107.3 150.9 146.2 151.2 145 164.8 178.4 155 154.4 158.9 192
Net income 1 100 91.6 87.5 48.7 45.4 89.4 87.7 91.4 85.3 87.6 112.5 100.6 97.68 102.9 120.6
Net margin 7.78% 6.95% 6.56% 3.66% 4.17% 7.86% 7.56% 7.7% 7.07% 7.03% 8.55% 7.71% 7.37% 7.56% 8.48%
EPS 2 1.000 0.9100 0.8700 0.4900 0.4500 0.8900 0.8700 0.9100 0.8400 0.8600 1.100 0.9833 0.9533 1.003 1.177
Dividend per Share 2 0.2800 0.2800 0.2800 0.2800 0.1500 - 0.1500 0.1500 - 0.1500 0.1500 0.1500 0.1500 0.1500 0.1500
Announcement Date 10/27/21 2/1/22 4/27/22 8/1/22 10/26/22 2/7/23 4/27/23 8/1/23 10/26/23 2/7/24 4/24/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,968 3,065 3,167 2,714 2,608 2,369 2,292 2,115
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.076 x 3.563 x 3.081 x 3.312 x 2.686 x 2.25 x 2.004 x 1.688 x
Free Cash Flow 1 517 309 187 141 268 268 266 279
ROE (net income / shareholders' equity) 27.3% 19.3% 24.2% 16.8% 23.8% 23.9% 20.1% 18.8%
ROA (Net income/ Total Assets) 6.37% 4.54% 6.37% 4.34% 6% 8.66% 8.85% 9.15%
Assets 1 5,628 6,263 6,476 6,251 5,869 4,784 5,177 5,352
Book Value Per Share 2 13.80 16.00 19.20 - - 27.60 28.80 34.40
Cash Flow per Share 2 6.390 7.060 7.140 7.030 8.400 8.530 9.490 10.10
Capex 1 372 396 529 565 583 544 614 679
Capex / Sales 8.09% 8.53% 10.33% 12.99% 12.14% 10.28% 10.68% 10.86%
Announcement Date 2/6/20 1/26/21 2/1/22 2/7/23 2/7/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Encompass Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
82.47 USD
Average target price
94.18 USD
Spread / Average Target
+14.20%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+23.61% 8.26B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+20.75% 7.2B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-5.01% 4.25B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. EHC Stock
  4. Financials Encompass Health Corporation